Evidence map›Paper›PMID 29216473›Full record

ArticlePhytochemistry2018

The natural sesquiterpene lactones arglabin, grosheimin, agracin, parthenolide, and estafiatin inhibit T cell receptor (TCR) activation.

Igor A Schepetkin, Liliya N Kirpotina, Pete T Mitchell, Аnarkul S Kishkentaeva, Zhanar R Shaimerdenova, Gayane A Atazhanova, Sergazy M Adekenov, Mark T Quinn

Abstract read
In one paragraph

Article in Phytochemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Exploring Sesquiterpene Lactones fromPlants (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Anti-Molecules (Basel, Switzerland) · 2021
    Article
  10. Molecules (Basel, Switzerland) · 2021
    Review
  11. Article
  12. Article
  13. Artemisinin and its derivatives: a potential therapeutic approach for oral lichen planus.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2019
    Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Igor A SchepetkinDepartment of Microbiology and Immunology, Montana State University, Bozeman, MT 59717, United States.
Liliya N KirpotinaDepartment of Microbiology and Immunology, Montana State University, Bozeman, MT 59717, United States.
Pete T MitchellDepartment of Microbiology and Immunology, Montana State University, Bozeman, MT 59717, United States.
Аnarkul S KishkentaevaInternational Research and Production Holding "Phytochemistry", Karaganda 100009, Kazakhstan.
Zhanar R ShaimerdenovaInternational Research and Production Holding "Phytochemistry", Karaganda 100009, Kazakhstan.
Gayane A AtazhanovaInternational Research and Production Holding "Phytochemistry", Karaganda 100009, Kazakhstan.
Sergazy M AdekenovInternational Research and Production Holding "Phytochemistry", Karaganda 100009, Kazakhstan.
Mark T QuinnDepartment of Microbiology and Immunology, Montana State University, Bozeman, MT 59717, United States. Electronic address: mquinn@montana.edu.
Montana State University · US

Funding

Pilot Grants ProgramP30GM110732 · NIGMS · MONTANA STATE UNIVERSITY - BOZEMAN · PI JUTILA, MARK A · 2014 to 2018
$5.4M
Center for Zoonotic and Emerging Infectious DiseasesP20GM103500 · NIGMS · MONTANA STATE UNIVERSITY - BOZEMAN · PI QUINN, MARK T · 2012 to 2013
$4.2M
NIGMS NIH HHS P20 GM103500NIGMS NIH HHS P30 GM110732
6 · The paper itself

Abstract

Inhibition of the T cell receptor (TCR) pathway represents an effective strategy for the treatment of T cell-mediated inflammatory and autoimmune diseases. To identify natural compounds that could inhibit inflammatory T cell responses, we screened 13 sesquiterpene lactones, including achillin, arglabin, argolide, argracin, 3β-hydroxyarhalin, artesin, artemisinin, estafiatin, grosheimin, grossmisin, leucomisine, parthenolide, and taurine, for their ability to modulate activation-induced Ca

Indexed as

Biological ProductsCell SurvivalDose-Response Relationship, DrugHumansNeutrophilsReceptors, Antigen, T-CellSesquiterpenesSesquiterpenes, GuaianeStructure-Activity RelationshipT-LymphocytesTumor Cells, CulturedarglabinBiological ProductsestafietingrosheiminparthenolideReceptors, Antigen, T-CellSesquiterpenesSesquiterpenes, GuaianeCalcium fluxGlutathioneJurkat T cellsKinasePhosphorylationSesquiterpene lactonesT cell receptor

Identifiers

PMID29216473
PMCPMC5750123
OpenAlexW2780381661

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.